GAL-021
CAS No. 1380341-99-0
GAL-021 ( GAL021;GAL 021 )
Catalog No. M11573 CAS No. 1380341-99-0
A novel respiratory stimulant that acts as a potent calcium-activated potassium (BKCa) channel blocker blocker.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 45 | In Stock |
|
5MG | 81 | In Stock |
|
10MG | 122 | In Stock |
|
25MG | 228 | In Stock |
|
50MG | 357 | In Stock |
|
100MG | 530 | In Stock |
|
500MG | 1152 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGAL-021
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel respiratory stimulant that acts as a potent calcium-activated potassium (BKCa) channel blocker blocker.
-
DescriptionA novel respiratory stimulant that acts as a potent calcium-activated potassium (BKCa) channel blocker blocker; reverses opioid-induced respiratory depression without compromising opioid analgesia in vivo. Respiratory insufficiencyOther Indication Phase 1 Clinical
-
SynonymsGAL021;GAL 021
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorBKCa-channel
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number1380341-99-0
-
Formula Weight254.33
-
Molecular FormulaC11H22N6O
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 30 mg/mL
-
SMILESCCCNC1=NC(N(OC)C)=NC(NCCC)=N1
-
Chemical Name1,3,5-Triazine-2,4,6-triamine, N2-methoxy-N2-methyl-N4,N6-dipropyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. McLeod JF, et al. Br J Anaesth. 2014 Nov;113(5):875-83.
2. Golder FJ, et al. Anesthesiology. 2015 Nov;123(5):1093-104.
3. Dallas ML, et al. Adv Exp Med Biol. 2015;860:361-70.
4. Roozekrans M, et al. Anesthesiology. 2014 Sep;121(3):459-68.
2. Golder FJ, et al. Anesthesiology. 2015 Nov;123(5):1093-104.
3. Dallas ML, et al. Adv Exp Med Biol. 2015;860:361-70.
4. Roozekrans M, et al. Anesthesiology. 2014 Sep;121(3):459-68.
molnova catalog
related products
-
Retigabine dihydroch...
Retigabine dihydrochloride is an anticonvulsant used as an adjunctive treatment for partial epilepsies in treatment-experienced adult patients.?The mechanism of action involves opening of neuronal K(V)7.2-7.5 (formerly KCNQ2-5) voltage-activated K(+) channels.In differentiated PC12 cells, retigabine enhanced a linopirdine-sensitive current.?
-
Gliquidone
Gliquidone is an anti-diabetic drug in the sulfonylurea class. It is used in the treatment of diabetes mellitus type 2.
-
JNJ 303
JNJ 303 is a potent blocker of IKs (IC50 : 64 nM).